Citation Impact
Citing Papers
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
2008 StandoutScience
Programmable RNA recognition using a CRISPR-associated Argonaute
2018 StandoutNobel
Sulfur [ 18 F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis
2021 StandoutNobel
Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons
2008 StandoutScience
Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
2006 StandoutScience
β-Catenin Controls Hair Follicle Morphogenesis and Stem Cell Differentiation in the Skin
2001 Standout
Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis
2002
The epidermis: rising to the surface
1994
A New Variant of Charcot-Marie-Tooth Disease Type 2 Is Probably the Result of a Mutation in the Neurofilament-Light Gene
2000
Inflammatory processes in amyotrophic lateral sclerosis
2002
Molecular imaging in drug development
2008 Standout
The Structural Basis for 14-3-3:Phosphopeptide Binding Specificity
1997 Standout
Diagnosis of amyotrophic lateral sclerosis
1998
Apoptosis in the nervous system
2000 StandoutNature
Genetic studies of amyotrophic lateral sclerosis: Controversies and perspectives
2009
The Ubiquitin Proteasome System in Neurodegenerative Diseases
2003 StandoutNobel
Mitochondria: Dynamic Organelles in Disease, Aging, and Development
2006 Standout
Motor Neuron Disease With Parkinsonism
1996
Upregulation of protein-tyrosine nitration in the anterior horn cells of amyotrophic lateral sclerosis
1997
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Age-Related Macular Degeneration
2008 Standout
Abnormal diffusion tensor in nonsymptomatic familial amyotrophic lateral sclerosis with a causative superoxide dismutase 1 mutation
2007
The genetic and molecular mechanisms of motor neuron disease
1998
Pathogenesis of two axonopathies does not require axonal neurofilaments
1998 Nature
Increased 3‐nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation
1997
Emerging pathways for hereditary axonopathies
2005
Phenotypic heterogeneity in motor neuron disease patients with CuZn- superoxide dismutase mutations in Scandinavia
1997
ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors
2006
From charcot to lou gehrig: deciphering selective motor neuron death in als
2001
The Use of Induced Pluripotent Stem Cells in Drug Development
2011 StandoutNobel
The genetic epidemiology of neurodegenerative disease
2005
Balancing Acts
2004 Standout
Review
1998
Amyotrophic lateral sclerosis
2011 Standout
A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes
2002
Linkage of Familial Amyotrophic Lateral Sclerosis With Frontotemporal Dementia to Chromosome 9q21-q22
2000
Increased 3‐nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis
1997
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Up‐Regulation of Protein Chaperones Preserves Viability of Cells Expressing Toxic Cu/Zn‐Superoxide Dismutase Mutants Associated with Amyotrophic Lateral Sclerosis
1999
Decoding ALS: from genes to mechanism
2016 StandoutNature
Oxidative stress in neurodegenerative diseases: therapeutic implications for superoxide dismutase mimetics
2003
Role of SOD-1 and nitric oxide/cyclic GMP cascade on neurofilament aggregation in ALS/MND
1996
Amyotrophic Lateral Sclerosis
2001
Functions of intermediate filaments in neuronal development and disease
2003
Unleashing the untold and misunderstood observations on vitamin E
2010
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Glial and neuronal control of brain blood flow
2010 StandoutNature
Cell Adhesion: The Molecular Basis of Tissue Architecture and Morphogenesis
1996 Standout
The Role of Oxidative Stress in Diabetic Complications
2005
A-to-I RNA Editing and Human Disease
2006
Diagnostic investigation and multidisciplinary management in motor neuron disease
2005
Translating preclinical insights into effective human trials in ALS
2006
Meta-Regression Analyses, Meta-Analyses, and Trial Sequential Analyses of the Effects of Supplementation with Beta-Carotene, Vitamin A, and Vitamin E Singly or in Different Combinations on All-Cause Mortality: Do We Have Evidence for Lack of Harm?
2013
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis
1995 Nature
Human stem cells and drug screening: opportunities and challenges
2010
Colocalization of NOS and SOD1 in neurofilament accumulation within motor neurons of amyotrophic lateral sclerosis: an immunohistochemical study
1996
Alzheimer's disease
2006 Standout
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Anti-Aβ Drug Screening Platform Using Human iPS Cell-Derived Neurons for the Treatment of Alzheimer's Disease
2011 StandoutNobel
Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neurone disease
2002
EP4 prostanoid receptor‐mediated vasodilatation of human middle cerebral arteries
2004
Preclinical Alzheimer's disease: diagnosis and prediction of progression
2005
Progress in the pathogenesis of amyotrophic lateral sclerosis
2001
Benefit of vitamin E, riluzole, and gababapentin in a transgenic model of familial amyotrophic lateral sclerosis
1996
Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention
2007 Standout
MicroRNAs as Potential Circulating Biomarkers for Amyotrophic Lateral Sclerosis
2014
Role of Free Radicals in the Neurodegenerative Diseases
2001 Standout
Alzheimer's Disease
2004 Standout
Oxidative stress in ALS: A mechanism of neurodegeneration and a therapeutic target
2006
Bioenergetic abnormalities in discrete cerebral motor pathways presage spinal cord pathology in the G93A SOD1 mouse model of ALS
2006
Oxidative stress and nitration in neurodegeneration: Cause, effect, or association?
2003
SOD1 mutation is assosiated with accumulation of neurofilaments in amyotrophic lateral scelaries
1996
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
2010 Standout
Novel drug development for amyotrophic lateral sclerosis
2000
Molecular biology of amyotrophic lateral sclerosis: insights from genetics
2006
Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis
1995
Amyotrophic Lateral Sclerosis
2001 Standout
Glia cells in amyotrophic lateral sclerosis: New clues to understanding an old disease?
2007
Matrix Elasticity Directs Stem Cell Lineage Specification
2006 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Identification of alternative splicing forms of GLT-1 mRNA in the spinal cord of amyotrophic lateral sclerosis patients
1998
Cytoskeletal abnormalities in amyotrophic lateral sclerosis: beneficial or detrimental effects?
2000
Copper Active Sites in Biology
2014 Standout
Luminescent Chemodosimeters for Bioimaging
2012 Standout
The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis
2001
Neuron-Specific Expression of Mutant Superoxide Dismutase 1 in Transgenic Mice Does Not Lead to Motor Impairment
2001
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Cognitive change in ALS
2005
A Structural Scaffolding of Intermediate Filaments in Health and Disease
1998 Science
Oxidative stress and nitration in neurodegeneration: Cause, effect, or association?
2003
From Charcot to SOD1
1999
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Familial amyotrophic lateral sclerosis
1997
Aromatic Sulfonyl Fluorides Covalently Kinetically Stabilize Transthyretin to Prevent Amyloidogenesis while Affording a Fluorescent Conjugate
2013 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Fluorescent Chemosensors Based on Spiroring-Opening of Xanthenes and Related Derivatives
2011 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Immature Copper-Zinc Superoxide Dismutase and Familial Amyotrophic Lateral Sclerosis
2009
Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review)
2009 Standout
Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase
1998
Excitotoxicity and Amyotrophic Lateral Sclerosis
2005
UNRAVELING THE MECHANISMS INVOLVED IN MOTOR NEURON DEGENERATION IN ALS
2004
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Catalytic Asymmetric Protonation of Silyl Ketene Imines
2013 StandoutNobel
Nonalcoholic Fatty Liver Disease
2015 Standout
14-3-3 proteins associate with phosphorylated simple epithelial keratins during cell cycle progression and act as a solubility cofactor.
1996
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
2005 Standout
Oxidative stress in neurodegeneration: cause or consequence?
2004 Standout
Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis
1999
Works of Michel Dib being referenced
A double-blind, placebo-controlled randomized clinical trial of α-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis
2001
Biomarkers in Amyotrophic Lateral Sclerosis
2009
Double-blind, comparative study of cyamemazine vs. bromazepam in the benzodiazepine withdrawal syndrome
2005
The Riluzole Early Access Programme: descriptive analysis of 844 patients in France
1997
Can malondialdehyde be used as a biological marker of progression in neurodegenerative disease?
2002
A longitudinal study of the evolution of cognitive function and affective state in patients with amyotrophic lateral sclerosis
2004
Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis
1994
Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients
2002
Efficacy of oral ketoprofen in acute migraine
2002
Double-blind study of cyamemazine and diazepam in the alcohol withdrawal syndrome
2005
A positron emission tomography (PET) study of cerebral dopamine D2 and serotonine 5-HT2A receptor occupancy in patients treated with cyamemazine (Tercian)
2005
Androgen receptor gene polymorphisms in amyotrophic lateral sclerosis
1993
Annual Rate and Predictors of Conversion to Dementia in Subjects Presenting Mild Cognitive Impairment Criteria Defined according to a Population-Based Study
2004
Identification of new mutations in the Cu/Zn superoxide dismutase gene of patients with familial amyotrophic lateral sclerosis.
1995